Insider Transactions in Q2 2021 at Ligand Pharmaceuticals Inc (LGND)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
Matthew E Korenberg President & COO |
BUY
Other acquisition or disposition
|
Direct |
247
+0.62%
|
$20,995
$85.91 P/Share
|
|
Jun 30
2021
|
John L Higgins Director |
BUY
Other acquisition or disposition
|
Direct |
247
+0.07%
|
$20,995
$85.91 P/Share
|
|
Jun 04
2021
|
Stephen L Sabba Director |
BUY
Grant, award, or other acquisition
|
Direct |
630
+2.45%
|
-
|
|
Jun 04
2021
|
Sunil Patel |
BUY
Grant, award, or other acquisition
|
Direct |
630
+2.14%
|
-
|
|
Jun 04
2021
|
John L Lamattina Director |
BUY
Grant, award, or other acquisition
|
Direct |
630
+2.42%
|
-
|
|
Jun 04
2021
|
John W Kozarich Director |
BUY
Grant, award, or other acquisition
|
Direct |
630
+1.78%
|
-
|
|
Jun 04
2021
|
Nancy Ryan Gray Director |
BUY
Grant, award, or other acquisition
|
Direct |
630
+14.54%
|
-
|
|
Jun 04
2021
|
Todd C Davis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
630
+1.23%
|
-
|
|
Jun 04
2021
|
Sarah Boyce |
BUY
Grant, award, or other acquisition
|
Direct |
630
+17.89%
|
-
|
|
Jun 04
2021
|
Jason Aryeh Director |
BUY
Grant, award, or other acquisition
|
Direct |
630
+0.91%
|
-
|
|
May 28
2021
|
Matthew W Foehr |
BUY
Exercise of conversion of derivative security
|
Direct |
1,755
+1.06%
|
$98,280
$56.26 P/Share
|
|
May 28
2021
|
Matthew W Foehr |
SELL
Bona fide gift
|
Direct |
2,500
-1.51%
|
-
|
|
May 11
2021
|
John W Kozarich Director |
SELL
Payment of exercise price or tax liability
|
Direct |
391
-1.13%
|
$50,048
$128.56 P/Share
|
|
May 11
2021
|
John W Kozarich Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,835
+12.28%
|
$48,350
$10.12 P/Share
|